25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CBI (Clal Biotechnology Industries Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Clal Biotechnology Industries Ltd together

I guess you are interested in Clal Biotechnology Industries Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Clal Biotechnology Industries Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Clal Biotechnology Industries Ltd’s Price Targets

I'm going to help you getting a better view of Clal Biotechnology Industries Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Clal Biotechnology Industries Ltd

I send you an email if I find something interesting about Clal Biotechnology Industries Ltd.

1. Quick Overview

1.1. Quick analysis of Clal Biotechnology Industries Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Clal Biotechnology Industries Ltd? (30 sec.)

How much money do you get?

How much money do you get?
ILA0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
ILA29.43
Expected worth in 1 year
ILA-162.46
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
ILA-191.89
Return On Investment
-627.1%

For what price can you sell your share?

Current Price per Share
ILA30.60
Expected price per share
ILA28.20 - ILA33.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Clal Biotechnology Industries Ltd (5 min.)




Live pricePrice per Share (EOD)
ILA30.60
Intrinsic Value Per Share
ILA-417.46 - ILA199.94
Total Value Per Share
ILA-388.03 - ILA229.37

2.2. Growth of Clal Biotechnology Industries Ltd (5 min.)




Is Clal Biotechnology Industries Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$13.6m$35.9m-$22.2m-163.0%

How much money is Clal Biotechnology Industries Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$18.4m-$9.1m-$9.3m-50.3%
Net Profit Margin0.0%-29,856.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Clal Biotechnology Industries Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Clal Biotechnology Industries Ltd?

Welcome investor! Clal Biotechnology Industries Ltd's management wants to use your money to grow the business. In return you get a share of Clal Biotechnology Industries Ltd.

First you should know what it really means to hold a share of Clal Biotechnology Industries Ltd. And how you can make/lose money.

Speculation

The Price per Share of Clal Biotechnology Industries Ltd is ILA30.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Clal Biotechnology Industries Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Clal Biotechnology Industries Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ILA29.43. Based on the TTM, the Book Value Change Per Share is ILA-47.97 per quarter. Based on the YOY, the Book Value Change Per Share is ILA-14.98 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ILA0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Clal Biotechnology Industries Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 ILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per Share
Usd Eps-0.12-0.4%-0.12-0.4%-0.06-0.2%-0.10-0.3%-0.05-0.2%-0.13-0.4%
Usd Book Value Change Per Share-0.14-0.5%-0.14-0.5%-0.04-0.1%-0.18-0.6%-0.17-0.5%-0.23-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.030.1%0.030.1%
Usd Total Gains Per Share-0.14-0.5%-0.14-0.5%-0.04-0.1%-0.18-0.6%-0.14-0.5%-0.20-0.7%
Usd Price Per Share0.10-0.10-0.12-0.14-0.27-0.52-
Price to Earnings Ratio-0.87--0.87--2.00--1.50--0.74--3.99-
Price-to-Total Gains Ratio-0.72--0.72--2.64--1.30-0.16-1.15-
Price to Book Ratio1.18-1.18-0.51-0.79-0.71-0.61-
Price-to-Total Gains Ratio-0.72--0.72--2.64--1.30-0.16-1.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0906372
Number of shares11032
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.03
Usd Book Value Change Per Share-0.14-0.17
Usd Total Gains Per Share-0.14-0.14
Gains per Quarter (11032 shares)-1,567.59-1,533.48
Gains per Year (11032 shares)-6,270.34-6,133.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-6270-62801168-7302-6144
20-12541-125502337-14604-12278
30-18811-188203505-21907-18412
40-25081-250904673-29209-24546
50-31352-313605842-36511-30680
60-37622-376307010-43813-36814
70-43892-439008178-51116-42948
80-50163-501709346-58418-49082
90-56433-5644010515-65720-55216
100-62703-6271011683-73022-61350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%4.011.00.026.7%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.07.00.030.0%6.09.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%4.00.06.040.0%4.00.011.026.7%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.07.00.030.0%6.09.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Clal Biotechnology Industries Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---47.972-47.9720%-14.976-69%-60.199+25%-55.867+16%-77.337+61%
Book Value Per Share--29.43329.4330%77.406-62%66.407-56%145.634-80%326.661-91%
Current Ratio--0.2900.2900%2.205-87%2.736-89%3.570-92%4.042-93%
Debt To Asset Ratio--0.3180.3180%0.233+36%0.253+26%0.232+37%0.233+36%
Debt To Equity Ratio--0.5880.5880%0.372+58%0.420+40%0.441+33%0.551+7%
Dividend Per Share----0%-0%-0%8.938-100%8.935-100%
Enterprise Value--3290263140.0003290263140.0000%2513309520.000+31%4005125200.000-18%8449055722.400-61%11890137636.080-72%
Eps---39.820-39.8200%-19.797-50%-32.993-17%-17.382-56%-44.000+10%
Free Cash Flow Per Share---4.130-4.1300%-5.431+31%-16.004+287%-19.451+371%-37.497+808%
Free Cash Flow To Equity Per Share---4.130-4.1300%-5.431+31%-11.742+184%-23.588+471%-22.587+447%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--199.938----------
Intrinsic Value_10Y_min---417.464----------
Intrinsic Value_1Y_max---8.253----------
Intrinsic Value_1Y_min---38.986----------
Intrinsic Value_3Y_max---3.238----------
Intrinsic Value_3Y_min---120.296----------
Intrinsic Value_5Y_max--27.769----------
Intrinsic Value_5Y_min---204.447----------
Market Cap4799487600.000-13%5442563140.0005442563140.0000%6211109520.000-12%7214925200.000-25%14510715722.400-62%27923417636.080-81%
Net Profit Margin----0%-298.5670%-155.1440%-93.0270%-48.4160%
Operating Margin----0%-0%-11.2670%-6.8210%-6.6770%
Operating Ratio----0%98.894-100%44.565-100%27.831-100%17.122-100%
Pb Ratio1.040-13%1.1791.1790%0.512+130%0.793+49%0.713+65%0.612+93%
Pe Ratio-0.768+12%-0.871-0.8710%-2.000+130%-1.497+72%-0.739-15%-3.986+357%
Price Per Share30.600-13%34.70034.7000%39.600-12%46.000-25%90.800-62%176.040-80%
Price To Free Cash Flow Ratio-7.409+12%-8.402-8.4020%-7.292-13%-5.783-31%-6.108-27%-3.857-54%
Price To Total Gains Ratio-0.638+12%-0.723-0.7230%-2.644+266%-1.303+80%0.162-545%1.154-163%
Quick Ratio--0.0530.0530%1.145-95%1.097-95%1.589-97%1.524-97%
Return On Assets---0.923-0.9230%-0.196-79%-0.486-47%-0.296-68%-0.207-78%
Return On Equity---1.705-1.7050%-0.313-82%-0.836-51%-0.534-69%-0.435-74%
Total Gains Per Share---47.972-47.9720%-14.976-69%-60.199+25%-46.929-2%-68.402+43%
Usd Book Value--13674073.00013674073.0000%35961049.600-62%30851204.667-56%68992681.200-80%153527953.860-91%
Usd Book Value Change Per Share---0.142-0.1420%-0.044-69%-0.178+25%-0.165+16%-0.229+61%
Usd Book Value Per Share--0.0870.0870%0.229-62%0.197-56%0.431-80%0.968-91%
Usd Dividend Per Share----0%-0%-0%0.026-100%0.026-100%
Usd Enterprise Value--9745759.4219745759.4210%7444422.798+31%11863180.842-18%25026103.050-61%35218587.678-72%
Usd Eps---0.118-0.1180%-0.059-50%-0.098-17%-0.051-56%-0.130+10%
Usd Free Cash Flow---1918783.600-1918783.6000%-2523031.600+31%-7435212.400+287%-9160695.880+377%-17535454.680+814%
Usd Free Cash Flow Per Share---0.012-0.0120%-0.016+31%-0.047+287%-0.058+371%-0.111+808%
Usd Free Cash Flow To Equity Per Share---0.012-0.0120%-0.016+31%-0.035+184%-0.070+471%-0.067+447%
Usd Market Cap14216082.271-13%16120872.02116120872.0210%18397306.398-12%21370608.442-25%42980739.970-62%82709163.038-81%
Usd Price Per Share0.091-13%0.1030.1030%0.117-12%0.136-25%0.269-62%0.521-80%
Usd Profit---18499467.200-18499467.2000%-9197306.200-50%-15328053.800-17%-8044969.720-57%-20586847.840+11%
Usd Revenue----0%30804.800-100%46799.600-100%9003235.960-100%10991982.000-100%
Usd Total Gains Per Share---0.142-0.1420%-0.044-69%-0.178+25%-0.139-2%-0.203+43%
 EOD+3 -5MRQTTM+0 -0YOY+11 -223Y+13 -205Y+11 -2410Y+15 -20

3.3 Fundamental Score

Let's check the fundamental score of Clal Biotechnology Industries Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.768
Price to Book Ratio (EOD)Between0-11.040
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.053
Current Ratio (MRQ)Greater than10.290
Debt to Asset Ratio (MRQ)Less than10.318
Debt to Equity Ratio (MRQ)Less than10.588
Return on Equity (MRQ)Greater than0.15-1.705
Return on Assets (MRQ)Greater than0.05-0.923
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Clal Biotechnology Industries Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose30.600
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Clal Biotechnology Industries Ltd

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel. It operates as a former subsidiary of Clal Industries and Investments Ltd.

Fundamental data was last updated by Penke on 2025-06-27 20:50:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Clal Biotechnology Industries Ltd earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that 0.00 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-29,856.7%+29,856.7%
TTM-5Y-9,302.7%+9,302.7%
5Y-9,302.7%10Y-4,841.6%-4,461.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--92.7%+92.7%
TTM--141.4%+141.4%
YOY-29,856.7%-186.1%-29,670.6%
3Y-15,514.4%-248.3%-15,266.1%
5Y-9,302.7%-338.6%-8,964.1%
10Y-4,841.6%-488.9%-4,352.7%
4.3.1.2. Return on Assets

Shows how efficient Clal Biotechnology Industries Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • -92.3% Return on Assets means that Clal Biotechnology Industries Ltd generated -0.92 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clal Biotechnology Industries Ltd:

  • The MRQ is -92.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -92.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-92.3%TTM-92.3%0.0%
TTM-92.3%YOY-19.6%-72.7%
TTM-92.3%5Y-29.6%-62.7%
5Y-29.6%10Y-20.7%-8.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-92.3%-11.5%-80.8%
TTM-92.3%-11.6%-80.7%
YOY-19.6%-11.4%-8.2%
3Y-48.6%-11.8%-36.8%
5Y-29.6%-12.1%-17.5%
10Y-20.7%-13.8%-6.9%
4.3.1.3. Return on Equity

Shows how efficient Clal Biotechnology Industries Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • -170.5% Return on Equity means Clal Biotechnology Industries Ltd generated -1.70 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clal Biotechnology Industries Ltd:

  • The MRQ is -170.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -170.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-170.5%TTM-170.5%0.0%
TTM-170.5%YOY-31.3%-139.2%
TTM-170.5%5Y-53.4%-117.1%
5Y-53.4%10Y-43.5%-9.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-170.5%-13.6%-156.9%
TTM-170.5%-14.9%-155.6%
YOY-31.3%-14.4%-16.9%
3Y-83.6%-17.0%-66.6%
5Y-53.4%-17.9%-35.5%
10Y-43.5%-20.1%-23.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Clal Biotechnology Industries Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Clal Biotechnology Industries Ltd is operating .

  • Measures how much profit Clal Biotechnology Industries Ltd makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-682.1%+682.1%
5Y-682.1%10Y-667.7%-14.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM--250.3%+250.3%
YOY--205.1%+205.1%
3Y-1,126.7%-220.2%-906.5%
5Y-682.1%-342.6%-339.5%
10Y-667.7%-475.5%-192.2%
4.3.2.2. Operating Ratio

Measures how efficient Clal Biotechnology Industries Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are 0.00 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY98.894-98.894
TTM-5Y27.831-27.831
5Y27.83110Y17.122+10.710
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM-2.704-2.704
YOY98.8943.063+95.831
3Y44.5653.576+40.989
5Y27.8314.713+23.118
10Y17.1226.512+10.610
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Clal Biotechnology Industries Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Clal Biotechnology Industries Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.29 means the company has 0.29 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.290. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.290. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.290TTM0.2900.000
TTM0.290YOY2.205-1.915
TTM0.2905Y3.570-3.280
5Y3.57010Y4.042-0.472
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2903.661-3.371
TTM0.2903.786-3.496
YOY2.2054.121-1.916
3Y2.7364.680-1.944
5Y3.5705.765-2.195
10Y4.0426.150-2.108
4.4.3.2. Quick Ratio

Measures if Clal Biotechnology Industries Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.05 means the company can pay off 0.05 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.053. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.053. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.053TTM0.0530.000
TTM0.053YOY1.145-1.092
TTM0.0535Y1.589-1.536
5Y1.58910Y1.524+0.065
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0532.826-2.773
TTM0.0533.128-3.075
YOY1.1453.782-2.637
3Y1.0974.304-3.207
5Y1.5895.703-4.114
10Y1.5246.454-4.930
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Clal Biotechnology Industries Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Clal Biotechnology Industries Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Clal Biotechnology Industries Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.32 means that Clal Biotechnology Industries Ltd assets are financed with 31.8% credit (debt) and the remaining percentage (100% - 31.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.318. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.318. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.318TTM0.3180.000
TTM0.318YOY0.233+0.085
TTM0.3185Y0.232+0.086
5Y0.23210Y0.233-0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3180.324-0.006
TTM0.3180.347-0.029
YOY0.2330.327-0.094
3Y0.2530.339-0.086
5Y0.2320.349-0.117
10Y0.2330.382-0.149
4.5.4.2. Debt to Equity Ratio

Measures if Clal Biotechnology Industries Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 58.8% means that company has 0.59 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.588. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.588. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.588TTM0.5880.000
TTM0.588YOY0.372+0.215
TTM0.5885Y0.441+0.147
5Y0.44110Y0.551-0.110
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5880.383+0.205
TTM0.5880.436+0.152
YOY0.3720.410-0.038
3Y0.4200.446-0.026
5Y0.4410.460-0.019
10Y0.5510.509+0.042
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Clal Biotechnology Industries Ltd generates.

  • Above 15 is considered overpriced but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • A PE ratio of -0.87 means the investor is paying -0.87 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clal Biotechnology Industries Ltd:

  • The EOD is -0.768. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.871. Based on the earnings, the company is expensive. -2
  • The TTM is -0.871. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.768MRQ-0.871+0.103
MRQ-0.871TTM-0.8710.000
TTM-0.871YOY-2.000+1.129
TTM-0.8715Y-0.739-0.133
5Y-0.73910Y-3.986+3.248
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.768-2.197+1.429
MRQ-0.871-2.027+1.156
TTM-0.871-2.527+1.656
YOY-2.000-3.733+1.733
3Y-1.497-3.717+2.220
5Y-0.739-6.036+5.297
10Y-3.986-6.649+2.663
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Clal Biotechnology Industries Ltd:

  • The EOD is -7.409. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.402. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.402. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.409MRQ-8.402+0.993
MRQ-8.402TTM-8.4020.000
TTM-8.402YOY-7.292-1.110
TTM-8.4025Y-6.108-2.294
5Y-6.10810Y-3.857-2.250
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.409-3.007-4.402
MRQ-8.402-2.704-5.698
TTM-8.402-3.627-4.775
YOY-7.292-4.334-2.958
3Y-5.783-5.070-0.713
5Y-6.108-8.532+2.424
10Y-3.857-9.305+5.448
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Clal Biotechnology Industries Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.18 means the investor is paying 1.18 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Clal Biotechnology Industries Ltd:

  • The EOD is 1.040. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.179. Based on the equity, the company is underpriced. +1
  • The TTM is 1.179. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.040MRQ1.179-0.139
MRQ1.179TTM1.1790.000
TTM1.179YOY0.512+0.667
TTM1.1795Y0.713+0.466
5Y0.71310Y0.612+0.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0401.921-0.881
MRQ1.1791.843-0.664
TTM1.1792.113-0.934
YOY0.5122.467-1.955
3Y0.7932.541-1.748
5Y0.7133.666-2.953
10Y0.6124.311-3.699
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Net Working Capital  18,281,500-14,085,6004,195,900-2,823,2001,372,700-569,800802,900-2,222,900-1,420,000



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in ILS. All numbers in thousands.

Summary
Total Assets67,688
Total Liabilities21,523
Total Stockholder Equity36,633
 As reported
Total Liabilities 21,523
Total Stockholder Equity+ 36,633
Total Assets = 67,688

Assets

Total Assets67,688
Total Current Assets5,796
Long-term Assets61,892
Total Current Assets
Cash And Cash Equivalents 3,953
Short-term Investments 1,058
Total Current Assets  (as reported)5,796
Total Current Assets  (calculated)5,011
+/- 785
Long-term Assets
Property Plant Equipment 1,526
Long-term Assets  (as reported)61,892
Long-term Assets  (calculated)1,526
+/- 60,366

Liabilities & Shareholders' Equity

Total Current Liabilities19,996
Long-term Liabilities1,527
Total Stockholder Equity36,633
Total Current Liabilities
Short Long Term Debt 19,165
Total Current Liabilities  (as reported)19,996
Total Current Liabilities  (calculated)19,165
+/- 831
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,678
Long-term Liabilities  (as reported)1,527
Long-term Liabilities  (calculated)1,678
+/- 151
Total Stockholder Equity
Total Stockholder Equity (as reported)36,633
Total Stockholder Equity (calculated)0
+/- 36,633
Other
Capital Stock1,613
Common Stock Shares Outstanding 156,846
Net Debt 15,212
Net Invested Capital 55,798
Net Working Capital -14,200
Property Plant and Equipment Gross 1,526



6.3. Balance Sheets Structured

Currency in ILS. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
442,461
425,921
936,321
1,363,970
1,250,536
1,749,349
1,921,343
1,687,603
1,532,772
1,118,710
1,034,340
1,016,081
616,965
614,031
444,918
182,690
158,386
67,688
67,688158,386182,690444,918614,031616,9651,016,0811,034,3401,118,7101,532,7721,687,6031,921,3431,749,3491,250,5361,363,970936,321425,921442,461
   > Total Current Assets 
0
0
0
0
0
0
184,957
446,386
307,645
191,351
185,228
139,113
137,355
211,094
77,610
16,639
14,691
5,796
5,79614,69116,63977,610211,094137,355139,113185,228191,351307,645446,386184,957000000
       Cash And Cash Equivalents 
257,386
214,894
190,105
87,129
43,061
50,152
83,429
191,704
240,292
165,630
164,247
40,366
37,551
68,157
53,049
7,443
5,729
3,953
3,9535,7297,44353,04968,15737,55140,366164,247165,630240,292191,70483,42950,15243,06187,129190,105214,894257,386
       Short-term Investments 
23,157
0
55,734
26,894
20,014
5,840
8,679
158,660
15,813
5,392
830
63,404
76,979
118,338
0
5,442
7,627
1,058
1,0587,6275,4420118,33876,97963,4048305,39215,813158,6608,6795,84020,01426,89455,734023,157
       Net Receivables 
0
0
0
0
0
0
14,208
12,461
18,784
16,415
11,534
27,450
14,294
8,892
5,534
650
0
0
006505,5348,89214,29427,45011,53416,41518,78412,46114,208000000
       Other Current Assets 
0
0
0
0
0
0
0
7,134
3,071
666
1,568
870
1,457
7,630
10,709
516
0
0
0051610,7097,6301,4578701,5686663,0717,1340000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
927,359
849,112
876,968
479,610
402,937
367,308
166,051
143,693
61,892
61,892143,693166,051367,308402,937479,610876,968849,112927,359000000000
       Property Plant Equipment 
2,913
3,308
6,250
3,385
2,684
7,293
10,809
10,222
17,077
16,536
14,854
7,786
16,318
14,943
18,064
5,090
4,733
1,526
1,5264,7335,09018,06414,94316,3187,78614,85416,53617,07710,22210,8097,2932,6843,3856,2503,3082,913
       Goodwill 
0
0
0
0
0
95,665
100,588
114,860
115,263
12,868
11,613
0
0
0
0
0
0
0
000000011,61312,868115,263114,860100,58895,66500000
       Long Term Investments 
0
0
0
0
0
0
131,653
174,091
165,850
164,841
202,376
208,961
0
0
0
0
0
0
000000208,961202,376164,841165,850174,091131,653000000
       Intangible Assets 
47,678
44,925
481,679
446,530
83,201
1,045,834
1,491,116
1,051,521
920,490
741,543
626,342
641,062
304,694
241,048
215,779
0
0
0
000215,779241,048304,694641,062626,342741,543920,4901,051,5211,491,1161,045,83483,201446,530481,67944,92547,678
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
927,359
849,112
876,968
479,610
1,268
2,499
927
2
0
029272,4991,268479,610876,968849,112927,359000000000
> Total Liabilities 
82,592
151,469
153,409
138,200
142,006
354,193
540,451
428,444
440,305
366,215
226,144
148,462
119,119
100,240
106,549
37,793
36,978
21,523
21,52336,97837,793106,549100,240119,119148,462226,144366,215440,305428,444540,451354,193142,006138,200153,409151,46982,592
   > Total Current Liabilities 
0
0
0
0
0
0
50,970
63,409
66,785
68,277
31,182
23,681
41,052
28,279
35,651
2,912
6,662
19,996
19,9966,6622,91235,65128,27941,05223,68131,18268,27766,78563,40950,970000000
       Short-term Debt 
0
0
0
0
0
0
118,091
86,690
85,202
78,306
71,875
0
10,944
0
0
0
0
0
0000010,944071,87578,30685,20286,690118,091000000
       Short Long Term Debt 
0
0
0
0
0
0
118,091
86,690
85,202
78,306
71,875
0
10,944
0
0
0
4,970
19,165
19,1654,97000010,944071,87578,30685,20286,690118,091000000
       Accounts payable 
7,232
17,226
8,981
14,200
22,174
15,654
22,359
9,844
14,782
8,507
7,975
10,567
14,104
9,622
14,600
0
0
0
00014,6009,62214,10410,5677,9758,50714,7829,84422,35915,65422,17414,2008,98117,2267,232
       Other Current Liabilities 
0
0
0
0
0
0
28,611
22,943
28,743
35,121
9,730
1,466
2,950
3,680
4,091
48
0
0
00484,0913,6802,9501,4669,73035,12128,74322,94328,611000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
297,938
194,962
124,781
78,067
71,961
70,898
34,881
30,316
1,527
1,52730,31634,88170,89871,96178,067124,781194,962297,938000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
-118,091
-86,690
-85,202
-78,306
-71,875
0
-1,983
7,735
11,682
9,339
4,822
1,678
1,6784,8229,33911,6827,735-1,9830-71,875-78,306-85,202-86,690-118,091000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
132,214
62,683
24,617
22,677
21,879
370
0
0
0
00037021,87922,67724,61762,683132,214000000000
> Total Stockholder Equity
331,214
254,317
532,165
991,077
1,079,341
953,968
866,109
679,205
552,896
363,074
382,115
398,898
223,599
306,346
172,594
126,027
99,358
36,633
36,63399,358126,027172,594306,346223,599398,898382,115363,074552,896679,205866,109953,9681,079,341991,077532,165254,317331,214
   Common Stock
861
861
915
982
1,020
1,020
1,210
1,343
1,362
1,362
1,565
1,613
1,613
1,613
1,613
1,613
0
0
001,6131,6131,6131,6131,6131,5651,3621,3621,3431,2101,0201,020982915861861
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
88,474
167,424
140,378
163,376
148,110
174,487
152,049
123,721
125,291
139,373
0
0
00139,373125,291123,721152,049174,487148,110163,376140,378167,42488,474000000



6.4. Balance Sheets

Currency in ILS. All numbers in thousands.




6.5. Cash Flows

Currency in ILS. All numbers in thousands.




6.6. Income Statements

Currency in ILS. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in ILS. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-6,628
Operating Income-6,628-6,628
 
Operating Expense (+$)
Research Development0
Selling General Administrative4,030
Selling And Marketing Expenses0
Operating Expense6,6284,030
 
Net Interest Income (+$)
Interest Income171
Interest Expense-3,566
Other Finance Cost-333
Net Interest Income-3,728
 
Pretax Income (+$)
Operating Income-6,628
Net Interest Income-3,728
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-75,074-6,628
EBIT - interestExpense = -3,566
-62,456
-58,890
Interest Expense3,566
Earnings Before Interest and Taxes (EBIT)0-71,508
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-75,074
Tax Provision-0
Net Income From Continuing Ops-75,074-75,074
Net Income-62,456
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net03,728
 

Technical Analysis of Clal Biotechnology Industries Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Clal Biotechnology Industries Ltd. The general trend of Clal Biotechnology Industries Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Clal Biotechnology Industries Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Clal Biotechnology Industries Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Clal Biotechnology Industries Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 32.00 < 32.50 < 33.50.

The bearish price targets are: 29.40 > 29.20 > 28.20.

Know someone who trades $CBI? Share this with them.👇

Clal Biotechnology Industries Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Clal Biotechnology Industries Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Clal Biotechnology Industries Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily Moving Average Convergence/Divergence (MACD) ChartClal Biotechnology Industries Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Clal Biotechnology Industries Ltd. The current adx is .

Clal Biotechnology Industries Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily Relative Strength Index (RSI) ChartClal Biotechnology Industries Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily Stochastic Oscillator ChartClal Biotechnology Industries Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily Commodity Channel Index (CCI) ChartClal Biotechnology Industries Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily Chande Momentum Oscillator (CMO) ChartClal Biotechnology Industries Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily Williams %R ChartClal Biotechnology Industries Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily Average True Range (ATR) ChartClal Biotechnology Industries Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily On-Balance Volume (OBV) ChartClal Biotechnology Industries Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Clal Biotechnology Industries Ltd.

Clal Biotechnology Industries Ltd Daily Money Flow Index (MFI) ChartClal Biotechnology Industries Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Clal Biotechnology Industries Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Clal Biotechnology Industries Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Clal Biotechnology Industries Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose30.600
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Clal Biotechnology Industries Ltd with someone you think should read this too:
  • Are you bullish or bearish on Clal Biotechnology Industries Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Clal Biotechnology Industries Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Clal Biotechnology Industries Ltd

I send you an email if I find something interesting about Clal Biotechnology Industries Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Clal Biotechnology Industries Ltd.

Receive notifications about Clal Biotechnology Industries Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.